MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Cerebral differences between dopamine-resistant and dopamine-responsive Parkinson’s tremor

    MF. Dirkx, H. Zach, A. van Nuland, BR. Bloem, I. Toni, RC. Helmich (Nijmegen, Netherlands)

  • Cerebral palsy masqueraders in an adult movement disorder tertiary centre: when to investigate an alternative diagnosis?

    S. Duarte, R. Martins, M. Magalhães (Porto, Portugal)

  • Cerebrotendinous Xanthomatosis presenting Parkinsonism with bilateral iron accumulation in the basal ganglia

    J. Li, S. Liu, E. Xu, H. Qiao, W. Mao, P. Chan (Beijing, China)

  • Certification of cause of death in patients with Parkinson’s Disease (PD)

    M. Khwaja, A. Chatterjee (Reading, United Kingdom)

  • Cervical and Lumbosacral Spondylosis is common in patients with Parkinsonism in rural Western India

    S. Desai (Anand, India)

  • Challenges in Parkinson’s Disease Diagnosis in a Patient with Ipsilateral Hemimelia

    G. Fabiani, FMB. Germiniani, HA. Teive (Curitiba, Brazil)

  • Change of extracellular glutamate and GABA level in striatum during deep brain stimulation of the entopeduncular nucleus in rats

    CB. Cho, JH. Sung (Suwon, Republic of Korea)

  • Changes in close relationships among patients with Parkinson’s disease and their partners following initiation of device-aided treatment

    J. Timpka, M. Scharfenort, T. Sahlström, V. Hernström, T. Henriksen, D. Nyholm, P. Odin (Lund, Sweden)

  • Changes in GABAergic transmission of striatal neurons in presymptomatic Huntington’s Disease

    M. Treven, F. Zirpel, I. Mody (Vienna, Austria)

  • Changes in Neuromelanin MRI Signal in Parkinson’s Disease: A Longitudinal Study

    R. Gaurav, L. Yahia-Cherif, G. Mangone, N. Pyatigorskaya, R. Valabregue, C. Ewenczyk, M. Hutchison, J. Corvol, M. Vidailhet, S. Lehéricy (Paris, France)

  • « Previous Page
  • 1
  • …
  • 34
  • 35
  • 36
  • 37
  • 38
  • …
  • 217
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley